Novel Method for Inducing Tissue Repair
Meenhard Herlyn and Mark Nesbit
Following simple injection, these viruses can induce the formation of either blood vessels (VEGF) or new stromal tissue (PDGF-B). The stimulation in vivo is self-limiting because the viruses are replication defective. These viruses may be useful for inducing wound healing and tissue repair in a variety of situations, including wound healing, reconstructive surgery and transplantation.
U.S. Patent No. 6,486,133.
Wistar is seeking an exclusive licensee and/or sponsored research to support the development of this technology.